Bioorganic & Medicinal Chemistry Letters · 1997 · 26 citations · 8 references
PharmacyMedicinal ChemistryPharmacologyChemotherapyDrug DesignDrug DiscoveryCytotoxic ChemotherapyEnzyme InhibitionOncology PharmacologyTopoisomerase InhibitorsAnticancer ActivityAnticancer Compound ScreeningBiological Evaluation ReportDna Topoisomerase Ii InhibitionPyrimidine AnaloguesTopoisomerase ActivityTopoisomerase Ii FunctionTopoisomerase Ii Inhibitors
Novel water-soluble 4β-amino-4′-O-demethylepipodophyllotoxin derivatives (6–12), designed to enhance minor groove binding ability, were synthesized and screened against NCI's in vitro disease-oriented human tumor cells. Among them, 4′-O-demethyl-4β-[N-(1‴-methyl-4‴-nitro-pyrrole-2‴-carbonyl)-4″-aminoanilino]-4-desoxypodophyllotoxin (10) and its HCl salt (11) were found to exhibit potent cytotoxic activities (average log GI50 = −6.91, −7.00, and −5.01 for 10, 11, and etoposide, respectively). Compounds 10 and 12 were further tested for their inhibitory activities against DNA topoisomerase II. Compound 10 again exhibited a superior activity profile compared to that of etoposide, displaying increased cytotoxicity against KB and KB-7d cells (ID50LD50 = 0.040.15 and 0.20.25 for KB and KB-7d cells, respectively), topoisomerase II inhibitory activity (12.5 μM), and cellular protein DNA complex formation (225%).
8
Zhe Qing Wang, Yao Haur Kuo, Dora M. Schnur et al. · Journal of Medicinal Chemistry · 1990 · 107 citations
Kuo Hsiung Lee, Scott A. Beers, Masami Mori et al. · Journal of Medicinal Chemistry · 1990 · 82 citations
Sung Jin Cho, Alexander Tropsha, Matthew Suffness et al. · Journal of Medicinal Chemistry · 1996 · 81 citations